ENT/ A decade of making a difference
These articles fall under two themes. The first is ENT (Ear, Nose and Throat) and the second is ‘a decade of making a difference’.
This year the NIHR celebrates it’s 10th year. With that in mind, two of our articles take a look back at the last decade; one from a personal point of view and the other from a specialty perspective. In contrast, our two ENT articles focus on the future, looking at studies that are investigating potential new approaches and treatments.
We caught up with Professor Jane Nixon, Deputy Director of the Leeds Clinical Trials Research Unit, who has recently been appointed as an NIHR Senior Investigator. This prestigious award recognises her contribution to research over the last decade.
In 2007, the clinical research environment for children underwent a major transformation. The European Union introduced its Paediatric Regulation, which meant that any company developing a drug for adults was legally obliged to consider how it could be developed for children.
It’s no coincidence that two years earlier, the NIHR introduced its Medicines for Children Research Network (MCRN). Over the last decade, this Network has helped to make the most of the opportunities presented by the EU Paediatric Regulation, to improve the delivery of clinical research in England for the benefit of children. Now known as Clinical Research Network (CRN) Children, the Network has contributed to a significant upturn in clinical research opportunities for children and young people in England.
Hearing loss can be a devastating long-term condition for children, but early intervention can reduce its negative impact on development and offer improved life opportunities.
The Manchester ‘hearing van’ study team took the time out from gathering evidence to improve hearing aid fittings for babies as young as three months old, to speak to us.
Ear, Nose and Throat (ENT) research in the UK has gone from strength to strength over the last decade. It has transformed from what was once considered a specialty with a deficit in high quality research, to one that has a thriving research community and a national research strategy. Insight Monthly talks to two key researchers who are driving recent developments in this area.